67 participants
A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-06
- Start Date:
- 2023-07-10
- Completion:
- 2028-08-31
Conditions
- Advanced Solid Tumors With MAPK Pathway Mutations
Interventions
- DRUG
No Results Yet